MAM
BMY icon

Mark Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Mark Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-104,263
Closed -$7.67M – 54
2016
Q2 		$7.67M Buy
+104,263
New +$7.37M 2.26% 19

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Mark Asset Management's BMY Position: Q3 2016 in Review

Mark Asset Management sold out of Bristol-Myers Squibb (BMY) in Q3 2016, closing a stake of 104,263 shares — an estimated $7.67M sold.

Mark Asset Management first reported a position in BMY in Q2 2016 and held it in 1 quarter. The position peaked at $7.67M in Q2 2016. 1,522 funds tracked by Wall St. Rank hold BMY as of Q3 2016.

  • Mark Asset Management reported no remaining Bristol-Myers Squibb position as of Q3 2016 after selling out during the quarter.
  • Mark Asset Management sold 104,263 Bristol-Myers Squibb shares in Q3 2016, an estimated $7.67M.
  • Mark Asset Management first reported a position in Bristol-Myers Squibb in Q2 2016 and held it in 1 quarter.
  • Mark Asset Management's Bristol-Myers Squibb position peaked at $7.67M in Q2 2016.
  • 1,522 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2016.

Based on Mark Asset Management's 13F filing for Q3 2016, filed 15 Nov 2016.